{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:11:16Z","timestamp":1788347476897,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T00:00:00Z","timestamp":1543017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003958","name":"Dutch Technology Foundation STW","doi-asserted-by":"publisher","award":["11823"],"award-info":[{"award-number":["11823"]}],"id":[{"id":"10.13039\/501100003958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jconrel.2018.11.019","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:51:17Z","timestamp":1542934277000},"page":"113-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys"],"prefix":"10.1016","volume":"293","author":[{"given":"Haili","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter N.","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels J.","family":"Sijbrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mies J.","family":"van Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel H.A.M.","family":"Fens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep B.","family":"van de Dikkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-1892","authenticated-orcid":false,"given":"Javier Sastre","family":"Tora\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim E.","family":"Hennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4933-3968","authenticated-orcid":false,"given":"Robbert Jan","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.11.019_bb0005","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addr.2004.01.008","article-title":"Folate-targeted chemotherapy","volume":"56","author":"Leamon","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0010","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/mp5000967","article-title":"Avidity mechanism of dendrimer-folic acid conjugates","volume":"11","author":"van Dongen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-409X(99)00062-9","article-title":"Targeted drug delivery via the folate receptor","volume":"41","author":"Sudimack","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/bc2005522","article-title":"Engineering folate-drug conjugates to target cancer: from chemistry to clinic","volume":"23","author":"Vlahov","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.addr.2012.09.020","article-title":"Folate-mediated delivery of macromolecular anticancer therapeutic agents","volume":"64","author":"Lu","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0035","doi-asserted-by":"crossref","first-page":"C517","DOI":"10.1152\/ajpcell.00006.2004","article-title":"Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy","volume":"287","author":"Sandoval","year":"2004","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0040","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"3090","article-title":"Demonstration of high-affinity folate binding activity associated with the brush border membranes of rat kidney","volume":"Vol. 75","author":"Selhub","year":"1978"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/bc300483a","article-title":"Radiosynthesis and preclinical evaluation of 3\u2032-Aza-2\u2032-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting","volume":"24","author":"Betzel","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bc9901447","article-title":"Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical","volume":"11","author":"Mathias","year":"2000","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0055","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/art.10405","article-title":"Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis","volume":"46","author":"Turk","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0060","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar3304","article-title":"Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate","volume":"13","author":"Lu","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2119\/molmed.2015.00040","article-title":"Antiinflammatory activity of a novel folic acid targeted conjugate of the mTOR inhibitor everolimus","volume":"21","author":"Lu","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0070","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","author":"Shillingford","year":"2012","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"issue":"2","key":"10.1016\/j.jconrel.2018.11.019_bb0075","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1152\/ajprenal.00057.2018","article-title":"Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease","volume":"315","author":"Kipp","year":"2018","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2014.137","article-title":"Translational research in ADPKD: lessons from animal models","volume":"10","author":"Happe","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0085","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000334166","article-title":"Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects","volume":"120","author":"Chang","year":"2012","journal-title":"Nephron. Clin. Pract."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0090","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14656566.2014.903923","article-title":"Pharmacological management of polycystic kidney disease","volume":"15","author":"W\u00fcthrich","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0095","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrneph.2016.61","article-title":"Polycystic kidney disease: Cilia and mechanosensation revisited","volume":"12","author":"Hofherr","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0100","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MNH.0b013e3283262ab0","article-title":"Advances in the pathogenesis and treatment of polycystic kidney disease","volume":"18","author":"Patel","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0110","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1681\/ASN.2013080864","article-title":"Scattered deletion of PKD1 in kidneys causes a cystic snowball effect and recapitulates polycystic kidney disease","volume":"26","author":"Leonhard","year":"2015","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0115","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jconrel.2018.11.019_bb0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases","author":"Torres","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0125","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1681\/ASN.2005050534","article-title":"Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase\/Akt signaling pathway","volume":"17","author":"Boca","year":"2006","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0140","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1158\/1535-7163.MCT-09-0160","article-title":"NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas","volume":"8","author":"Liu","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2015.04.028","article-title":"Dual blockade of PI3K\/AKT\/mTOR (NVP-BEZ235) and Ras\/Raf\/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models","volume":"138","author":"Schrauwen","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1634\/theoncologist.2016-0145","article-title":"A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma","volume":"21","author":"Carlo","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0155","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/2472555217716056","article-title":"High-throughput phenotypic screening of kinase inhibitors to identify drug targets for polycystic kidney disease","volume":"22","author":"Booij","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0160","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1038\/s41598-018-22938-x","article-title":"Dual mTOR\/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0165","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1021\/nn500498t","article-title":"Bundled assembly of helical nanostructures in polymeric micelles loaded with platinum drugs enhancing therapeutic efficiency against pancreatic tumor","volume":"8","author":"Mochida","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/cmdc.201402496","article-title":"Platinum(II) as bifunctional linker in antibody-drug conjugate formation: coupling of a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore to trastuzumab as a model","volume":"10","author":"Waalboer","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0175","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1681\/ASN.2007070794","article-title":"Inhibition of renal rho kinase attenuates ischemia\/reperfusion-induced injury","volume":"19","author":"Prakash","year":"2008","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0180","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2008.08.013","article-title":"Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors","volume":"132","author":"Fretz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/0008-5472.CAN-16-1900","article-title":"A novel platinum (II)\u2013based bifunctional ADC linker benchmarked using 89Zr-Desferal and Auristatin F\u2013conjugated Trastuzumab","volume":"77","author":"Sijbrandi","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2018.11.019_bb0190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijpharm.2017.10.032","article-title":"PLGA-PEG nanoparticles for targeted delivery of the mTOR\/PI3kinase inhibitor dactolisib to inflamed endothelium","volume":"548","author":"Gholizadeh","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0195","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/bc500376j","article-title":"Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor","volume":"25","author":"Nkepang","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2015.10.044","article-title":"Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells","volume":"76","author":"Ahir","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2012.05.033","article-title":"Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection","volume":"901","author":"Lin","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0210","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1039\/C5CC09074A","article-title":"Fluorescent supramolecular nanoparticles signal the loading of electrostatically charged cargo","volume":"52","author":"Gra\u00f1a-Su\u00e1rez","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0215","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1021\/nn402644g","article-title":"Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors","volume":"7","author":"Vlashi","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0220","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1021\/jo100448q","article-title":"Carbohydrate-based synthetic approach to control toxicity profiles of folate-drug conjugates","volume":"75","author":"Vlahov","year":"2010","journal-title":"J. Organ. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0225","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/bc0600158","article-title":"Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug\u2212 albumin conjugates using platinum (II)-based drug linker technology","volume":"17","author":"Temming","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0230","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/jpet.106.114496","article-title":"Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells","volume":"321","author":"Gonzalo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2016.03.038","article-title":"Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines","volume":"230","author":"Wang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0240","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1039\/b901612k","article-title":"Synthesis and applications of Rhodamine derivatives as fluorescent probes","volume":"38","author":"Beija","year":"2009","journal-title":"Chem. Soc. Rev."},{"issue":"111","key":"10.1016\/j.jconrel.2018.11.019_bb0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2005.12.010","article-title":"Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology","author":"Gonzalo","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0250","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-08-1385","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations","volume":"68","author":"Serra","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0255","first-page":"2204","article-title":"NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas","volume":"8","author":"Liu","year":"2009","journal-title":"Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0260","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.carbon.2013.12.039","article-title":"Hyaluronic acid conjugated graphene oxide for targeted drug delivery","volume":"69","author":"Wu","year":"2014","journal-title":"Carbon"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/nep.12045","article-title":"Role of interstitial inflammation in the pathogenesis of polycystic kidney disease","volume":"18","author":"Ta","year":"2013","journal-title":"Nephrology"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0270","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1158\/0008-5472.CAN-07-0033","article-title":"Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate","volume":"67","author":"Reddy","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0275","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.08.041","article-title":"Imatinib-ULS-lysozyme: a proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases","volume":"157","author":"Dolman","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0280","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6602772","article-title":"Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats","volume":"93","author":"Uchino","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0285","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/adfm.201403095","article-title":"Gold nanoclusters-based nanoprobes for simultaneous fluorescence imaging and targeted photodynamic therapy with superior penetration and retention behavior in tumors","volume":"25","author":"Zhang","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0290","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/bc500074a","article-title":"Targeted decationized polyplexes for cell specific gene delivery","volume":"25","author":"Novo","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0295","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/bc060401p","article-title":"In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing Adriamycin in the intracellular acidic compartments","volume":"18","author":"Bae","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0300","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/S0021-9258(17)41848-5","article-title":"Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis","volume":"269","author":"Lee","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/bc9500709","article-title":"Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging","volume":"7","author":"Wang","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0310","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/bc400441s","article-title":"Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship","volume":"25","author":"Leamon","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0315","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/mp500017u","article-title":"Synthetic polyglutamylation of dual-functional MTX ligands for enhanced combined cytotoxicity of poly(I:C) nanoplexes","volume":"11","author":"Lachelt","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0320","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1016\/j.bmcl.2013.08.113","article-title":"Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate","volume":"23","author":"Henne","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0325","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/mp900158d","article-title":"Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors","volume":"6","author":"Vlashi","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0330","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nimb.2017.04.073","article-title":"Extension of activation cross section data of long lived products in deuteron induced nuclear reactions on platinum up to 50 MeV","volume":"401","author":"Ditr\u00f3i","year":"2017","journal-title":"Nucl. Instrum. Methods Phys. Res., Sect. B"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0335","doi-asserted-by":"crossref","unstructured":"R. del Campo, J.J. Criado, E. Garc\u0131\u0301a, M.R. Hermosa, A. Jimenez-Sanchez, J.L. Manzano, E. Monte, E. Rodr\u0131guez-Fern\u00e1ndez, F. Sanz, Thiourea derivatives and their nickel (II) and platinum (II) complexes: antifungal activity, J. Inorg. Biochem., 89 (2002) 74\u201382.","DOI":"10.1016\/S0162-0134(01)00408-1"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.106.106054","article-title":"Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular cells: a novel strategy to treat renal fibrosis","volume":"319","author":"Prakash","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0345","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/bc0600158","article-title":"Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum (II)-based drug linker technology","volume":"17","author":"Temming","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0350","first-page":"4137","article-title":"MRI-detectable polymeric micelles incorporating platinum anticancer drugs enhance survival in an advanced hepatocellular carcinoma model","volume":"10","author":"Vinh","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.11.019_bb0355","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2967\/jnumed.117.206672","article-title":"In vivo characterization of platinum (II)-based linker technology for the development of antibody\u2013drug conjugates: taking advantage of dual labeling with 195mPt and 89Zr","volume":"59","author":"Muns","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0360","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1002\/anie.200250653","article-title":"Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change","volume":"42","author":"Bae","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2018.11.019_bb0365","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1681\/ASN.2004080711","article-title":"Renal tubular reabsorption of folate mediated by folate binding protein 1","volume":"16","author":"Birn","year":"2005","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918306655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918306655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:13:58Z","timestamp":1775279638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918306655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":73,"alternative-id":["S0168365918306655"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.11.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}